Various studies have revealed remarkably upregulated Tf levels in malignant cells compared to normal cells (Candelaria et al., 2021), making the conception of drugs targeting Tf a burgeoning research area in lung cancer therapy (Daniels et al., 2012). Here, TF is linked to lung cancer.